Historical record - last NADAC effective date: 7/20/2022
Product Information
ALENDRONATE SODIUM 35 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.3369 per EA under NDC 00115167926. Its NADAC has been published 262 times since Aug 9, 2017.
FDA first approved this application on Feb 6, 2008.
Strength
35 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115167926
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/20/2022
Active Ingredients
ALENDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA075710FDA Approved
2/6/2008
On Market Since
2/6/2008
Pharmacological Classes
Price Statistics
The NADAC for ALENDRONATE SODIUM 35 MG TAB has been published 262 times since Aug 9, 2017, and over the history we have for it it has declined 35.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3369 per EA |
|---|---|
| All-time high | $0.5422 (Oct 11, 2017) |
| All-time low | $0.3369 (Jul 20, 2022) |
| Median price | $0.4243 |
| Average price | $0.4288 |
| Largest weekly change | +19.6% (May 22, 2019) |
| Weeks tracked | 262 |
| Tracking since | Aug 9, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-18.3%
All
-35.4%
Last surveyed Aug 10, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alendronate Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bisphosphonate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALENDRONATE SODIUM 35 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALENDRONATE SODIUM 35 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.3369 per EA (NDC 00115167926), effective Aug 10, 2022.
How has the price of ALENDRONATE SODIUM 35 MG TAB changed over time?
Over the history we have for it, the NADAC for ALENDRONATE SODIUM 35 MG TAB has declined 35.4%. It has been tracked across 262 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for ALENDRONATE SODIUM 35 MG TAB?
Since Aug 9, 2017, the NADAC for ALENDRONATE SODIUM 35 MG TAB has ranged from a low of $0.3369 (Jul 20, 2022) to a high of $0.5422 (Oct 11, 2017), with a median of $0.4243 per EA.
Are there cheaper alternatives to ALENDRONATE SODIUM 35 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALENDRONATE SODIUM 35 MG TAB, is $0.2813 per EA — about 17% below ALENDRONATE SODIUM 35 MG TAB.
Who manufactures ALENDRONATE SODIUM 35 MG TAB?
ALENDRONATE SODIUM 35 MG TAB (NDC 00115167926) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.